Additional file 2: of Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf

A375 growth data. Single-treatment of 10 μM PPL-008C and PPL-008CSS significantly attenuated A375 cell (V700E malignant melanoma cell line) growth although pERK levels are unaffected by these treatments (see Fig. 1.). (PPTX 118 kb)